 |
tesevatinib |
|---|---|
| Trade Name | |
| Orphan Indication | Non-small cell lung cancer |
| USA Market Approval | USA |
| USA Designation Date | 2017-08-03 00:00:00 |
| Sponsor | Kadmon Corporation, LLC;450 East 29th Street;New York, New York, 10016 |
Related Access Program
| |
tesevatinib |
|---|---|
| Trade Name | |
| Orphan Indication | Non-small cell lung cancer |
| USA Market Approval | USA |
| USA Designation Date | 2017-08-03 00:00:00 |
| Sponsor | Kadmon Corporation, LLC;450 East 29th Street;New York, New York, 10016 |